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Abstract
Etoposide (VP-16) is known to promote cell apoptosis either in cancer or in normal cells
as a side effect. This fact is preceded by the induction of several mitochondrial events,
including increase in Bax/Bcl-2 ratio followed by cytochrome c release and consequent
activation of caspase-9 and -3, reduction of ATP levels, depolarization of membrane
potential () and rupture of the outer membrane. These events are apoptotic factors
essentially associated with the induction of the mitochondrial permeability transition (MPT).
VP-16 has been shown to stimulate the Ca2+-dependent MPT induction similarly to
prooxidants and to promote apoptosis by oxidative stress mechanisms, which is prevented by
glutathione (GSH) and N-acetylcysteine (NAC). Therefore, the aim of this work was to
study the effects of antioxidants and thiol protecting agents on MPT promoted by VP-16,
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attempting to identify the underlying mechanisms on VP-16-induced apoptosis. The in-
creased sensitivity of isolated mitochondria to Ca2+-induced swelling, Ca2+ release, depo-
larization of  and uncoupling of respiration promoted by VP-16, which are prevented by
cyclosporine A proving that VP-16 induces the MPT, are also efficiently prevented by
ascorbate, the primary reductant of the phenoxyl radicals produced by VP-16. The thiol
reagents GSH, dithiothreitol and N-ethylmaleimide, which have been reported to prevent the
MPT induction, also protect this event promoted by VP-16. The inhibition of the VP-16-in-
duced MPT by antioxidants agrees with the prevention of etoposide-induced apoptosis by
GSH and NAC and suggests the generation of oxidant species as a potential mechanism
underlying the MPT that may trigger the release of mitochondrial apoptogenic factors
responsible for apoptotic cascade activation. © 2002 Elsevier Science Ireland Ltd. All rights
reserved.
Keywords: Etoposide; Anticancer; Apoptosis; Mitochondrial permeability transition; Antioxidants;
Oxidative stress
1. Introduction
Etoposide (VP-16), a semisynthetic derivative of podophyllotoxin, is an anti-tu-
mor effective single agent also currently used as an important component of the
chemotherapeutic approach to a variety of hematopoietic and solid tumors [1].
VP-16 is a cytotoxic agent by either interacting directly with macromolecular
targets or by generating reactive oxygen (O2) species (ROS) [2,3]. Recently, it has
been reported that its cytotoxicity is mediated by triggering mitochondrial events
that seem to be obligatory steps of early (pre-nuclear) apoptosis. Such events
include the release of cytochrome c from mitochondria and disruption of outer
membrane due to mitochondrial permeability transition (MPT) induction [4,5],
which precedes the activation of caspase 9 and 3 [6,7], the reduction of mitochon-
drial membrane potential () and the formation of ultracondensed mitochondria
[8]. The destructive effects on the outer membrane integrity, with subsequent release
of the intermembrane apoptogenic factors from mitochondria, could also suggest
the involvement of VP-16-induced MPT on the activation of apoptotic cascade
[9,10]. Moreover, different studies confirm that cells treated with MPT inducers
alone undergo apoptosis and that, at least in most models of apoptosis, the
induction of MPT and mitochondrial cytochrome c release are essential compo-
nents of the apoptotic pathway [11–13]. On the other hand, cells undergoing
VP-16-induced apoptosis, which is prevented by glutathione (GSH) and N-acetyl-
cysteine (NAC) [7], also evidence a significant increase in the generation of ROS
[14], mitochondrial NO production [15] and induction of MnSOD [16]. Further-
more, VP-16 induces peroxide formation and depletion of GSH in cells during the
apoptotic process [17], suggesting the occurrence of GSH oxidation or cleavage of
the catalytic subunit of -glutamilcysteine synthetase [17], probably due to the
intermediate formation of hydroxyl and phenoxyl radicals [2,3].
Therefore, considering that the oxidation of thiol groups by ROS and/or other
oxidants, in addition to other oxidative stress mechanisms, has been proposed as a
critical factor regulating the induction of the MPT [18,19] and apoptosis [20,21], the
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mechanisms underlying VP-16-promoted apoptosis may involve cellular oxidative
stress and MPT induction. Ascorbate (Asc), GSH and protein thiols are known to
be major intracellular reductants that may reduce the VP-16 phenoxyl radicals,
preventing its cytotoxic effects [3]. Thus, the aim of this work was to study the
effects of two major water-soluble intracellular antioxidants, Asc and GSH, and of
the thiol protecting agents, dithiothreitol (DTT) and N-ethylmaleimide (NEM), on
VP-16-induced MPT to clarify the underlying mechanisms of MPT induction by
this drug and its potential relationship with the reported prevention of VP-16-in-
duced apoptosis by GSH and NAC [7].
2. Materials and methods
2.1. Chemicals
Etoposide (VP-16), 4-(2-hydroxymethyl)-1-piperazineethanesulfonic acid
(HEPES), ascorbic acid, glutathione, DTT, bovine serum albumin (BSA), cy-
closporine (CyA) and oligomycin were purchased from Sigma Chemical Co. (St.
Louis, MO). Ethylene glycol-bis(-aminoethyl ether)NNN N -tetraacetic acid
(EGTA), tetraphenylphosphonium (TPP+) and sucrose were from Merck (Darm-
stadt, Germany). All the other chemicals were of research grade. Solutions were
prepared in deionized ultra pure water.
2.2. Rat lier mitochondria
Hepatic mitochondria were isolated from Wistar rats (200–300 g) by differential
centrifugation [22]. The liver was quickly homogenized with a glass Potter-type
homogenizer and Teflon pestle in ice-cold isolation medium containing 250 mM
sucrose, 10 mM HEPES (pH 7.4) and 1 mM EGTA, supplemented with 0.1% BSA.
The homogenate was centrifuged at 800×g for 10 min at 4 °C. The mitochondrial
pellet was recovered from the supernatant by centrifugation at 10 000×g for 10
min and was washed twice in the ice-cold isolation medium adjusted to pH 7.2 in
the absence of EGTA and BSA. Fresh mitochondria with a respiratory control
ratio (RCR) (state 3/state 4 respiration) of about 5 were used within 4 h for all
assays.
2.3. Standard incubation procedure
Mitochondria were suspended in a standard reaction medium containing 200 mM
sucrose, 10 mM Tris–Mops (pH 7.4), 1 mM KH2PO4 and 10 M EGTA,
supplemented with 2 M rotenone and 0.5 g oligomycin/ml. VP-16, prepared in
dimethyl sulfoxide and diluted in standard reaction medium immediately prior each
experiment, was added to the reaction medium after protein addition and incubated
for 5 min before starting the reactions. Where indicated by the arrows, 1 M CyA,
40 M NEM, Asc, GSH and DTT (1 mol/mg protein) were added prior to VP-16
J.B.A. Custo´dio et al. / Chemico-Biological Interactions 140 (2002) 169–184172
incubation with mitochondria. The results represent typical recordings from exper-
iments of at least three different mitochondrial preparations.
2.4. Mitochondrial swelling
Mitochondrial osmotic volume changes were followed by monitoring continu-
ously the decrease in apparent absorbance (light-scattering) at 540 nm as described
elsewhere [23], except that mitochondria (0.5 mg protein/ml) in 2 ml of reaction
medium were supplemented with 140 nmol Ca2+/mg protein before energization
with succinate. In addition, negative controls for GSH and Asc effects were carried
out by pre-incubating the mitochondria with mixtures of oxidized GSH (GSSG)
plus GSH peroxidase and dehydroascorbic acid (DHA) plus Asc oxidase,
respectively.
2.5. Measurement of mitochondrial membrane potential
Estimation of membrane potential () was performed using a TPP+-sensitive
electrode prepared according to Kamo et al. [24]. Mitochondria (1 mg/2 ml) were
suspended in the reaction medium supplemented with 4 M TPP+ and energized
with 5 mM succinate. After a steady-state distribution of TPP+ has been reached
(ca. 2 min of recording), Ca2+ (200 nmol/mg protein) was added and  recorded
for 12 additional minutes. Mitochondrial  was evaluated by the transmembrane
distribution of TPP+ as previously described [23,25].
2.6. Mitochondrial Ca2+ fluxes and O2 consumption
Mitochondrial Ca2+ fluxes and O2 consumption were evaluated in parallel in the
same mitochondrial preparation. The changes in Ca2+ fluxes across the inner
mitochondrial membrane were monitored using a Ca2+-sensitive electrode accord-
ing to previously described procedures [23,26] and O2 uptake was estimated with a
Clark-type electrode (Yellow Springs Instrument Co., Model YSI 5331) as de-
scribed elsewhere [27]. The reactions were performed with 1 mg protein in 1 ml of
the reaction medium and the experiments were started with 5 mM succinate after 1
min of Ca2+ addition (180 nmol/mg protein) in the absence and presence of VP-16.
2.7. Simultaneous ealuation of  and O2 consumption
The effects of VP-16 on the mitochondrial respiration and  were measured
simultaneously at 25 °C in 1 ml of the respiratory medium containing 130 mM
sucrose, 50 mM KCl, 5 mM MgCl2, 0.1 mM EGTA, 5 mM KH2PO4, 5 mM Hepes,
pH 7.4, 2 M rotenone and 4 M TPP+. O2 consumption was monitored
polarographically with a Clark-type electrode and  was measured with a TPP+
electrode, as described before, inserted in the same closed O2 reaction chamber.
Mitochondria (1 mg) were energized with 5 mM succinate and, after steady-state
distribution of TPP+, ADP (150 nmol/mg protein) was added to initiate state 3
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respiration and O2 concentration and  were monitored continuously until
resumption of state 4.
3. Results
The effects of antioxidants and thiol compounds on mitochondrial swelling
induced by VP-16, as monitored spectrophotometrically at 540 nm, are shown in
Fig. 1. As we have previously reported [5], VP-16 (1 mol/mg protein–500 M)
increases the sensitivity of mitochondria to undergo a rapid and large decrease in
the absorbance due to MPT induced by Ca2+ (140 nmol/mg protein) (Fig. 1, trace
1) since it is prevented by CyA (1 M) (Fig. 1, trace 7), a potent and specific
inhibitor of the MPT. The VP-16 concentrations used to promote MPT were
relatively high as compared to those reported in pre-incubations with cells for
24–48 h to induce apoptosis [7,14,17]. Actually, since these incubation times are not
feasible in mitochondrial studies, our experiments were carried out with higher
VP-16 concentrations, as also reported by other studies (0.25 to 2 mM) [2,3,28,29],
but incubated with mitochondria only for 5 min before starting the reactions.
Therefore, a dose-response curve of VP-16 was performed to calculate the drug
Fig. 1. Inhibitor effects of Asc, glutathione (GSH) and NEM on VP-16-induced Ca2+-dependent
mitochondrial swelling. Mitochondria (0.5 mg protein/ml) incubated at 30 °C in 2 ml of standard
reaction medium, supplemented with 2 M rotenone and 0.5 g oligomycin/ml, were energized with 5
mM succinate after addition of either VP-16 (1 mol/mg protein) (6), Ca2+ (140 nmol/mg protein) (5)
or VP-16 plus Ca2+ (1). Asc (1 mM) (4), GSH (1 mM) (2) and NEM (40 M) (3) were pre-incubated
with mitochondria before addition of VP-16 and their protective effects were compared to that afforded
by CyA (1 M) (7). Mitochondrial swelling was followed continuously by the light-scattering at 540 nm
and the traces are typical direct recordings from three to four separate experiments.
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concentrations able to increase the sensitivity of isolated mitochondria to Ca2+-in-
duced swelling due to MPT induction. The minor concentration (1 mol/mg
protein–500 M) was used in experiments of Ca2+-dependent MPT induction.
The extensive VP-16-induced swelling observed when mitochondria are incubated
with VP-16 plus Ca2+ (Fig. 1, trace 1) is completely prevented by pre-incubating
the mitochondria, prior to VP-16 addition, with either Asc (1 mol/mg protein)
(Fig. 1, trace 4), the primary reductant of the phenoxyl radical of etoposide [3], or
GSH (1 mol/mg protein) (Fig. 1, trace 2) but, at the same concentrations, GSH
shows a lower protective effect than Asc. Noteworthy that their oxidized forms,
GSSG and DHA, did not show any suppressive effects on VP-16-induced MPT
(results not shown), according to the reported absence of effects on VP-16-induced
apoptosis. The monofunctional sulfhydryl alkylating agent NEM (40 M) (Fig. 1,
trace 3) has a similar effect to GSH in preventing VP-16-induced mitochondrial
swelling. The fact that the effects of VP-16 are prevented by Asc, GSH and NEM,
but not by DHA and GSSG, suggests the involvement of oxidative events, as
reported to other MPT inducers whose action mechanism has been recognized to be
mediated by dithiol and pyridine nucleotides oxidation [30,31].
The induction of MPT involving oxidative stress generated by VP-16 is further
evidenced in Fig. 2 that reports the effects of this drug on mitochondrial membrane
potential (). Adding Ca2+, at the concentration of 200 nmol/mg protein, to
energized mitochondria with succinate causes an immediate, yet transient, depolar-
ization of  that recovers within 2.5 min (Fig. 2, trace 1). In the presence of
VP-16 (Fig. 2, trace 2), Ca2+ promotes a gradual and irreversible depolarization of
, which is completely prevented by CyA (Fig. 2, trace 3) added to mitochondria
before VP-16 incubation, as we have previously reported [5]. Similarly, the addition
of either Asc (Fig. 2, trace 4) or GSH (Fig. 2, trace 5), the two major water-soluble
intracellular antioxidants, as also the thiol protecting agent DTT (1 mol/mg
protein) (Fig. 2, trace 6) to mitochondria before the pre-incubation with VP-16
affords complete protection against the Ca2+-induced irreversible depolarization of
.
Further evidence for the oxidative events as a mechanism underlying VP-16-in-
duced MPT is also provided by the complete protection of those compounds
against both the release of loaded Ca2+ (Fig. 3) and the uncoupling of Ca2+-stim-
ulated respiration (Fig. 4) caused by VP-16. Mitochondria energized with succinate
accumulate and retain Ca2+ taken up within about 20 min (Fig. 3, trace 1). In
accordance with the results of mitochondrial swelling and  referred above,
mitochondria previously exposed to VP-16 for 5 min at 30 °C are unable to sustain
the loaded Ca2+, occurring an irreversible release of the accumulated Ca2+ (Fig. 3,
trace 2) which is completely prevented by CyA (Fig. 3, trace 5) that affords to
mitochondria complete capacity to accumulate and retain the sequestered Ca2+.
The addition of either DTT (Fig. 3, trace 3), GSH (Fig. 3, trace 4) or Asc (Fig. 3,
trace 6) to mitochondria before VP-16 also provides full protection against the
Ca2+-induced irreversible release of the mitochondrial Ca2+-loaded. The protective
effect of Asc (Fig. 3, trace 6) against the VP-16-induced actions is remarkable and
Asc-treated mitochondria can withstand successive additions of Ca2+, in a total of
about 300 nmol without becoming uncoupled or releasing the Ca2+ taken up.
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Fig. 2. Protection against VP-16-induced irreversible depolarization of  by Asc, glutathione (GSH)
and DTT. Mitochondria, at 0.5 mg protein/ml, in the standard reaction medium supplemented with 2
M rotenone, 0.5 g oligomycin/ml and 4 M TPP+ were incubated at 30 °C and  was recorded
continuously using a TPP+ selective electrode, as described in Section 2. The reactions were initiated
with 5 mM succinate and after a steady-state distribution of TPP+ either in the absence (1) or presence
of 1 mol VP-16/mg protein incubated with mitochondria for 5 min (2) Ca2+ was added (200 nmol/mg
protein). CyA (1 M) (3), Asc (4), GSH (5) and DTT (6), at concentrations of 1 mol/mg protein, were
pre-incubated with mitochondria before adding VP-16. The recordings are typical of three independent
experiments.
Fig. 4 shows the effects of VP-16 on respiration at the same reaction conditions
as described to Fig. 3, depicting mitochondrial Ca2+ fluxes. Adding Ca2+ (180
nmol/mg protein) to mitochondria induces stimulation of the O2 consumption,
which returns to state 4 after repolarization of  (Fig. 2, trace 1) and accumula-
tion of the added Ca2+ (Fig. 3, trace 1), as we have previously reported [5].
However, mitochondria pre-incubated for 5 min with VP-16 undergo complete
uncoupling of respiration after addition of Ca2+ (Fig. 4, trace 2), which parallels
the irreversible depolarization of  (Fig. 2, trace 2) and release of the Ca2+
accumulated (Fig. 3, trace 2). Addition of either DTT (Fig. 4, trace 3), GSH (Fig.
4, trace 4) or Asc (Fig. 4, trace 5) to mitochondria, prior to the pre-incubation with
the drug, completely prevents the uncoupling of Ca2+-stimulated mitochondrial
respiration caused by VP-16. Worthy of notice is that although NEM prevents the
VP-16-induced mitochondrial swelling, it dramatically reduces the accumulation of
Ca2+ (Fig. 3, trace 7) and the transient stimulation of respiration by Ca2+ (Fig. 4,
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trace 6), as previously described [22], suggesting particular effects on either the
Ca2+ transport or the Ca2+-dependent respiratory pathways as a consequence of
the inhibition of phosphate transport protein.
As shown above (Fig. 3, trace 6), the efficiency of Asc in protection of
mitochondria against VP-16-induced Ca2+ release is noticeable. Actually, Asc
mimics CyA (Fig. 5), a specific MPT inhibitor that increases dramatically the
capacity of mitochondria to accumulate Ca2+ without succumbing to uncoupled
respiration (Fig. 5). This clearly suggests that Asc prevents the thiol groups’
oxidation or other oxidative events putatively involved in the MPT induced by
VP-16 due to the generation of oxidant species.
Fig. 3. Inhibitory effects of Asc, glutathione (GSH), DTT and NEM on mitochondrial Ca2+ release
associated with MPT induced by VP-16. Mitochondria were incubated for 5 min at 30 °C in the
standard reaction medium in the absence (1) and presence of VP-16 (2). Where indicated, DTT (3), GSH
(4), CyA (5), Asc (6), at concentrations indicated in legend to Fig. 2, and NEM (40 M) (7) were
pre-incubated with mitochondria before addition of VP-16. Following the pre-incubation period, Ca2+
was added (180 nmol/mg protein) and mitochondria were energized with 5 mM succinate. The uptake
of Ca2+ and the release of sequestered Ca2+ by mitochondria were monitored continuously with a
Ca2+-selective electrode. In the experiment with Asc (6), mitochondria were supplemented with
successive additions of 40 nmol Ca2+/mg protein. All traces are representative of 3–4 independent
experiments.
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Fig. 4. Prevention of VP-16-induced mitochondrial respiration uncoupling by either DTT, glutathione
(GSH), Asc, or NEM. Mitochondria, at 0.5 mg protein/ml, in the standard reaction medium supple-
mented with 2 M rotenone and 0.5 g oligomycin/ml, were incubated at 30 °C in the absence (1) and
presence (2) of VP-16 (1 mol/mg protein). O2 consumption was monitored using a Clarke-type O2
electrode placed in a closed reaction chamber. DTT (3), GSH (4), Asc (5) or NEM (6) were
pre-incubated with mitochondria before VP-16 addition. The traces represent typical recordings from
three separate experiments with different mitochondrial preparations.
The concentrations of VP-16 used in these experiments neither affect signifi-
cantly the  (Fig. 6) nor the respiratory chain (Fig. 7), as evaluated simulta-
neously with a TPP+ and an O2-sensitive electrodes, respectively, placed in the
same closed reaction chamber. The pre-incubation of mitochondria with VP-16
depresses slightly the total developed  as compared with the FCCP-induced
depolarization (Fig. 6). The depressive effect of VP-16, with a maximum depolar-
ization degree of about −35 mV to 2 mol/mg protein (Fig. 6), associated with
the changes on the phosphorylation cycle induced by ADP suggest that VP-16
does not significantly affect the phosphorylation capacity of mitochondria. In
fact, VP-16, at concentrations used to induce MPT (1 mol/mg protein–500
M), does not alter either state-3 or -4 respiration (Fig. 7), indicating that RCR
of mitochondria is not sensitive to these drug concentrations. Moreover, the
ADP/O ratio, as a measure of the efficiency of mitochondrial oxidative phospho-
rylation, is not changed (Fig. 7). However, at concentrations of 1.5 and 2 mol/
mg protein, VP-16 lengthens the lag phase preceding repolarization (Fig. 6) and
induces a moderate decrease in ADP/O and RCR indexes (Fig. 7), proving the
slightly depressive effect on the phosphorylation efficiency of mitochondria.
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4. Discussion
Mitochondria undergo a Ca2+-dependent MPT that has been implicated in
different cell functions [32,33] and in the mechanisms of toxic tissue injury caused
by different compounds [34,35], playing a central role in the activation of necrosis
and apoptosis pathways [6,9,36,37].
The MPT induction is strongly regulated by both  and pH components of
the mitochondrial protonmotive force, divalent cations and different metabolites
[38], in addition to the thiol redox status of cysteine residues in the vicinity of the
voltage sensor of the pore that determines the probability of MPT induction
[18,19,30]. Moreover, the MPT possesses at least two redox-sensitive sites, one of
them in equilibrium with GSH of mitochondrial matrix and another that can be
Fig. 5. Prevention of VP-16-induced mitochondrial respiration uncoupling by CyA. O2 consumption was
monitored as described in the legend to Fig. 4 using a Clarke-type O2 electrode. Mitochondria were
pre-incubated with CyA (1 M) before addition of VP-16 (1 mol/mg protein). After energization with
succinate (Succ) mitochondria were loaded with 180 nmol Ca2+/mg protein and supplemented with
successive additions of 40 nmol Ca2+/mg protein. The traces represent typical recordings from at least
three independent experiments.
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Fig. 6. Effect of VP-16 concentration on the mitochondrial transmembrane potential (). Mitochon-
dria (1 mg) suspended in the respiratory medium supplemented with 4 M TPP+ and 2 M rotenone
were energized with 5 mM succinate (Succ) after incubation at 25 °C for 5 min in the presence of
different VP-16 concentrations (mol VP-16/mg protein) indicated by the values adjacent to the traces.
Mitochondrial  was evaluated with a TPP+ selective electrode placed in a closed reaction chamber
as described in Section 2. ADP (150 nmol/mg protein) was added after a steady-state distribution of
TPP+ to induce state 3 respiration. The addition of FCCP (1 M) after ADP phosphorylative cycle
promotes the depolarization of . The recordings are typical of 3–4 independent experiments.
directly activated by ROS [30]. Therefore, in addition to the oxidation of membrane
protein sulfhydryl groups, the oxidation of both GSH and NAD(P)H of mitochon-
drial matrix [30], followed closely by an increase in the mitochondrial Ca2+ and
ROS generation within mitochondria (or a decreasing in their detoxification),
contributes to the MPT induction, as shown by studies with several MPT inducers,
including tert-butylhydroperoxide [39–42] and inorganic phosphate [31,43]. Besides
the generation of ROS, NO can also act on mitochondria amplifying the signals
promoting the MPT [44,45].
On the other hand, in vitro studies have shown that VP-16 is an effective
scavenger of peroxyl radicals [28], in agreement with its capacity to inhibit the
NAD(P)H/daunomicin-induced lipid peroxidation in liver microsomes [46]. How-
ever, the oxidation of VP-16 leads to the formation of phenoxyl radicals [2,3], that
promote selective oxidation of protein thiols [28], and to the generation of ROS
[14–17]. Ascorbate and several thiols reduce the VP-16-derived phenoxyl radicals,
as indicated by electron spin resonance and thiol oxidation measurements [3,28].
Moreover, the prevention of VP-16-induced apoptosis by GSH and NAC [7], an
J.B.A. Custo´dio et al. / Chemico-Biological Interactions 140 (2002) 169–184180
antioxidant and precursor of GSH, suggests that an oxidative shift in the cell redox
state and/or an increase in generation of oxidant species should be implicated in the
mechanisms underlying the cell death induced by this drug. Therefore, VP-16-pro-
moted oxidative events, including the oxidation of NAD(P)H, GSH and specific
protein thiols, could contribute to trigger the MPT induction. This hypothesis is
supported by our observation that Asc, which reduces the phenoxyl radical of
VP-16 [3] and inhibits the thiol oxidation induced by this drug [28], prevents the
VP-16-induced mitochondrial swelling (Fig. 1), depolarization of  (Fig. 2), Ca2+
release (Fig. 3) and uncoupling of respiration (Fig. 4), the events that characterize
the MPT induction. Moreover, these effects are also prevented by GSH (Figs. 1–4)
which, besides several cellular functions [47,48], plays a pivotal role in the regula-
tion of apoptosis [49], inhibiting the VP-16-induced apoptosis [7]. Similar inhibitor
effects on these mitochondrial events are caused by the thiol protecting agent DTT
(Figs. 1–4) that like NEM has been demonstrated to provide strong protection
against oxidant-induced increases in the voltage gating of the MPT [18,19]. How-
ever, the protection provided by NEM against the mitochondrial swelling (Fig. 1,
trace 3) and its induced decrease in the Ca2+-stimulation of respiration (Fig. 4,
trace 6) may be in part due to the partial inhibition of phosphate (Pi) carrier and
to the consequent decrease in the accumulation of Ca2+ (Fig. 3, trace 7) required
to trigger the MPT induction. In addition, it should be taken into account its effects
Fig. 7. Effect of VP-16 concentration on the mitochondrial O2 consumption. O2 consumption was
monitored as described in the legend to Fig. 6, using a Clarke-type O2 electrode placed in the same
closed reaction chamber. Mitochondria (1 mg) suspended in the respiratory medium were energized with
5 mM succinate (Succ) after incubation at 25 °C for 5 min in the presence of different VP-16
concentrations (mol VP-16/mg protein) indicated by the values adjacent to the traces. ADP (150
nmol/mg protein) was added to induce state 3 respiration. The recordings are typical of three
independent experiments.
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either on the thiol redox status [18,42,43,50] of the MPT or on the mitochondrial
bioenergetics, as previously reported [22].
Noteworthy that VP-16 increases the sensitivity of isolated mitochondria to the
Ca2+-induced depolarization of  (Fig. 2), and promotes the uncoupling of
Ca2+-stimulated mitochondrial respiration (Fig. 4), without significant effect on
 (Fig. 6), respiratory control and ADP/O ratios (Fig. 7) in the absence of Ca2+.
Taken together, these results demonstrate that VP-16 decreases the  of mito-
chondria putatively due to a futile cycling of either protons or potassium ions, as
also suggested by Robertson et al. [4], being unable to act as a mobile proton
carrier (Figs. 6 and 7) in contrast to the hypothetic mitochondrial uncoupling effect
of VP-16 proposed elsewhere [4]. Consequently, the effects of VP-16, at the
concentrations used in this study, are probably due to a direct action on the
Ca2+-dependent MPT megachannel complex.
Since the compounds that prevent the VP-16-induced MPT do not affect the
mitochondrial functional activities, our data, taken together with those on the
oxidative stress effects of VP-16 in cells undergoing apoptosis [7,14,16] and on
VP-16-induced oxidation of protein thiol groups [28], suggest that MPT promoted
by VP-16 is related to oxidative stress caused by oxidant species generated by this
drug [2,3], leading to changes in the redox status of mitochondrial NAD(P)H, GSH
and protein thiol groups oxidation.
Studies concerning the involvement of oxidative stress in apoptosis have also
provided evidence that ROS play an important role in the signaling mechanisms for
the default pathway of apoptosis. Moreover, ROS have also been implicated on the
release of cytochrome c and other apoptosis-inducing factors, as well as on the
upstream of caspases involved in the apoptotic cascade [10,51–53]. Although it has
been reported that in cytochrome c-induced cell death, cytochrome c release may
occur by both MPT-dependent and independent mechanisms, several studies have
shown that MPT and cytochrome c release are early events in several model of
apoptosis [4,6,7,19,54]. Moreover, the pro-apoptotic protein Bax, implicated in the
release of cytochrome c, has been suggested to translocate from the cytosol to
mitochondria in cells under the action of VP-16, a process that is prevented by the
anti-apoptotic protein Bcl-2 [53], which inhibits the MPT by keeping the pyridine
nucleotides in a relative reduced state [42,55]. Therefore, in cells undergoing
VP-16-induced apoptosis, it has been shown an increase in the Bax/Bcl-2 ratio,
followed by cytochrome c release and caspase-9 and -3 activation, and its inhibition
by GSH and NAC [7]. Such observations, together with our data, point to the
generation of oxidant species promoted by VP-16 as a mechanism underlying the
induction of MPT and the promotion of apoptosis.
In conclusion, this work provides evidence that oxidative stress plays an impor-
tant role in the induction of the MPT by VP-16, according to its oxidant effects in
cells undergoing apoptosis. Triggering of the MPT by VP-16, leading to mitochon-
drial swelling (causing mechanical disruption of the outer membrane and release of
apoptogenic factors), depolarization of , uncoupling of respiration (reducing
ATP levels) and mitochondrial Ca2+ release (a prerequisite for post-mitochondrial
events involved in caspase activation), could be regarded as a key pathway involved
in apoptosis induced by VP-16.
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